Halle drug company heralds new Alzheimer's treatment
A German pharmaceutical research company in Halle has developed a groundbreaking new treatment for Alzheimer's disease, daily Mitteldeutsche Zeitung reported on Monday.
“We are confident that our findings offer the possibility to stop or prevent the disease's destruction of nerve cells and the formation of deposits,” Probiodrug co-founder Hans-Ulrich Demuth told the paper.
But it will take at least seven years of clinical tests and development before the Halle-based company can market the product to people with the common and devastating form of dementia that effects the elderly, he said.
The company has taken out more than 27 patents to protect their work on the Alzheimer's drug.
Comments
See Also
“We are confident that our findings offer the possibility to stop or prevent the disease's destruction of nerve cells and the formation of deposits,” Probiodrug co-founder Hans-Ulrich Demuth told the paper.
But it will take at least seven years of clinical tests and development before the Halle-based company can market the product to people with the common and devastating form of dementia that effects the elderly, he said.
The company has taken out more than 27 patents to protect their work on the Alzheimer's drug.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.